$JOBY
Joby Aviation, Inc.

2021 Q1 Form 10-Q Financial Statement

#000119312521162336 Filed on May 17, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $11.64M $940.6K
YoY Change
% of Gross Profit
Research & Development $34.18M $31.80M
YoY Change
% of Gross Profit
Depreciation & Amortization $3.333M $2.240M
YoY Change
% of Gross Profit
Operating Expenses $45.83M $940.6K
YoY Change
Operating Profit -$45.83M
YoY Change
Interest Expense $863.0K -$62.76M
YoY Change
% of Operating Profit
Other Income/Expense, Net $4.327M $220.0K
YoY Change
Pretax Income -$41.50M -$63.70M
YoY Change
Income Tax $4.000K $10.00K
% Of Pretax Income
Net Earnings -$41.51M -$63.70M
YoY Change 63.66%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$601.5K -$738.5K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $870.0K $1.695M
YoY Change
Cash & Equivalents $116.8M $77.34M
Short-Term Investments
Other Short-Term Assets $430.0K $507.5K
YoY Change
Inventory
Prepaid Expenses $426.1K $3.032M
Receivables
Other Receivables $2.227M
Total Short-Term Assets $1.299M $451.2M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $34.13M
YoY Change
Goodwill $0.00
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments $690.0M $10.99M
YoY Change
Other Assets $262.0K
YoY Change
Total Long-Term Assets $690.0M $46.07M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.299M $451.2M
Total Long-Term Assets $690.0M $46.07M
Total Assets $691.3M $497.3M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $162.8K $4.928M
YoY Change
Accrued Expenses $373.1K $361.1K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $580.5K $8.005M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $82.51M $124.3M
YoY Change
Total Long-Term Liabilities $82.51M $124.3M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $580.5K $8.005M
Total Long-Term Liabilities $82.51M $124.3M
Total Liabilities $83.09M $12.11M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$23.30M -$296.3M
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$318.1M -$283.2M
YoY Change
Total Liabilities & Shareholders Equity $691.3M $497.3M
YoY Change

Cashflow Statement

Concept 2021 Q1 2020 Q4
OPERATING ACTIVITIES
Net Income -$41.51M -$63.70M
YoY Change 63.66%
Depreciation, Depletion And Amortization $3.333M $2.240M
YoY Change
Cash From Operating Activities -$29.67M -$649.9K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $5.082M $5.570M
YoY Change
Acquisitions $0.00
YoY Change
Other Investing Activities -$797.0K $0.00
YoY Change
Cash From Investing Activities -$5.879M $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 74.99M -435.0K
YoY Change
NET CHANGE
Cash From Operating Activities -29.67M -649.9K
Cash From Investing Activities -5.879M 0.000
Cash From Financing Activities 74.99M -435.0K
Net Change In Cash 39.45M -1.085M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$29.67M -$649.9K
Capital Expenditures $5.082M $5.570M
Free Cash Flow -$34.75M -$6.220M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
691320350
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1291919
CY2021Q1 us-gaap Liabilities
Liabilities
83089135
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
873032
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
426105
CY2021Q1 us-gaap Assets Current
AssetsCurrent
1299137
CY2021Q1 us-gaap Assets Held In Trust
AssetsHeldInTrust
690021213
CY2021Q1 us-gaap Assets
Assets
691320350
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
162796
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
373101
CY2021Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
44587
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
580484
CY2021Q1 rtp Deferred Legal Fees Noncurrent
DeferredLegalFeesNoncurrent
239161
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23296107
CY2021Q1 rtp Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
24150000
CY2021Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
58119490
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
603231210
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28293519
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1291919
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
79847
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-41818550
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
41898397
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
40606478
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000007
CY2021Q1 rtp Stock Issued During Period Value Common Stock Subject To Possible Redemption
StockIssuedDuringPeriodValueCommonStockSubjectToPossibleRedemption
-40606480
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000005
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
79847
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-41818550
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-81360
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
147021
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
12001
CY2021Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
110
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1051647
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
230000
CY2021Q1 rtp Change In Value Of Class A Ordinary Shares Subject To Possible Redemption
ChangeInValueOfClassAOrdinarySharesSubjectToPossibleRedemption
-44317850
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
690000000
CY2021Q1 rtp Trust Account Per Share
TrustAccountPerShare
10.00
CY2021Q1 rtp Percentage Of Fair Market Value To Assets Held In Trust Account
PercentageOfFairMarketValueToAssetsHeldInTrustAccount
0.80
CY2021Q1 rtp Voting Percentage
VotingPercentage
0.50
CY2021Q1 rtp Redeeming Share Percent
RedeemingSharePercent
0.15
CY2021Q1 rtp Business Combination Redeem Price Percentage
BusinessCombinationRedeemPricePercentage
1.00
CY2021Q1 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
194000
CY2021Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000
CY2021Q1 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
500000
CY2020Q3 rtp Cash Paid From Sponsor
CashPaidFromSponsor
25000
CY2020Q3 rtp Ordinary Shares Received
OrdinarySharesReceived
14375000
CY2020Q3 rtp Aggregate Shares Held By Sponsor
AggregateSharesHeldBySponsor
17250000
CY2020Q3 rtp Founder Shares
FounderShares
30000
CY2021Q1 rtp Issuance Of Warrants Shares
IssuanceOfWarrantsShares
11533333
CY2021Q1 rtp Gross Proceeds From Sponsor
GrossProceedsFromSponsor
17300000
CY2020Q3 rtp Loans Amounts
LoansAmounts
300000
CY2020Q3 rtp Borrowed Amount
BorrowedAmount
194000
CY2020Q3 rtp Working Capital Loans
WorkingCapitalLoans
2500000
CY2020Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.50
CY2020Q4 rtp Prepaid Amount
PrepaidAmount
468750
CY2021Q1 rtp Working Capitals
WorkingCapitals
500000
CY2021Q1 rtp Additional Sale Of Stock
AdditionalSaleOfStock
9000000
CY2021Q1 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
0.20
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001819848
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 rtp Trust Account Description
TrustAccountDescription
maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Shell Company
EntityShellCompany
true
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; background: none;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div> <div style="text-indent: 4%; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; background: none;"><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1 rtp Class A Common Stock Subject To Possible Redemption
ClassACommonStockSubjectToPossibleRedemption
<div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; background: none;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Class&#160;A Ordinary Shares Subject to Possible Redemption </div></div></div> <div style="text-indent: 4%; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; background: none;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class&#160;A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Class&#160;A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class&#160;A ordinary shares (including Class&#160;A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) are classified as temporary equity. At all other times, Class&#160;A ordinary shares are classified as shareholders&#8217; equity. The Company&#8217;s Class&#160;A ordinary shares feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, at March&#160;31, 2021, 60,323,121 Class&#160;A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders&#8217; equity section of the Company&#8217;s balance sheet. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; background: none;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div> <div style="text-indent: 4%; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; background: none;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000, and investments held in Trust Account. At March&#160;31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1 rtp Warrants To Be Issued Description
WarrantsToBeIssuedDescription
Each Unit consists of one Class A ordinary share and one-quarter of one redeemable warrant (&#8220;Public Warrant&#8221;). Each whole Public Warrant will entitle the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 6).
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1694679
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
507465
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2202144
CY2020Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
690171366
CY2020Q4 us-gaap Assets
Assets
692373510
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15775
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
361100
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
44697
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
421572
CY2020Q4 rtp Deferred Legal Fees Noncurrent
DeferredLegalFeesNoncurrent
239161
CY2020Q4 rtp Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
24150000
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
99938040
CY2020Q4 us-gaap Liabilities
Liabilities
124748773
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
562624730
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
68899593
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63902585
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
692373510
CY2021Q1 rtp Reimbursable Expenses Incurred
ReimbursableExpensesIncurred
513000
CY2021Q1 rtp Underwriting Agreement Description
UnderwritingAgreementDescription
The underwriters were entitled to an underwriting discount of $0.20 per unit, or $13.8 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $24.2 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 rtp Warrant Expire Term
WarrantExpireTerm
P5Y
CY2021Q1 rtp Gross Proceeds Price Percentage
GrossProceedsPricePercentage
0.60
CY2021Q1 rtp Warrants Description
WarrantsDescription
the volume weighted average trading price of Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial business Combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described below under &#8220;Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00&#8221; and &#8220;Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00&#8221; will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below under &#8220;Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00&#8221; will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 rtp Cash Withdrawn From Trust Account
CashWithdrawnFromTrustAccount
230000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-821647
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Reinvent Technology Partners
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Entity File Number
EntityFileNumber
001-39524
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1548118
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
215 Park Avenue
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Floor 11
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10003
CY2021Q1 dei City Area Code
CityAreaCode
212
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
457-1272
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 rtp Income On Trust Account
IncomeOnTrustAccount
40600000

Files In Submission

Name View Source Status
0001193125-21-162336-index-headers.html Edgar Link pending
0001193125-21-162336-index.html Edgar Link pending
0001193125-21-162336.txt Edgar Link pending
0001193125-21-162336-xbrl.zip Edgar Link pending
d924178d10q.htm Edgar Link pending
d924178dex311.htm Edgar Link pending
d924178dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rtp-20210331.xml Edgar Link completed
rtp-20210331.xsd Edgar Link pending
rtp-20210331_cal.xml Edgar Link unprocessable
rtp-20210331_def.xml Edgar Link unprocessable
rtp-20210331_lab.xml Edgar Link unprocessable
rtp-20210331_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending